A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza
Conditions: Grippe; Influenza; Vaccines Interventions: Biological: PF-07985819 pdmFlu Vaccine; Biological: Placebo; Biological: Quadrivalent influenza vaccine (QIV) Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
H7HLAII DNA Influenza Vaccine
Conditions: Influenza A; Pandemic Influenza Interventions: Biological: H7HLAII Sponsors: Oslo University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults
Condition: Influenza Interventions: Biological: mRNA-1018 for H5N8; Biological: mRNA-1018 for H7N9; Biological: mRNA-1018 for H5 Only; Biological: mRNA-1018 for H7 Only; Biological: mRNA-1018 for H5 Only-CG Sponsor: ModernaTX, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials